Statements (13)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:chemical_compound
|
| gptkbp:CASNumber |
142821-92-3
|
| gptkbp:chemicalClass |
quinazolinone derivative
|
| gptkbp:has_potential_therapeutic_use |
treatment of type 2 diabetes
|
| gptkbp:hasMolecularFormula |
C28H20Cl2N2O4
|
| gptkbp:hasSMILES |
COC1=C(C=CC(=C1)OC)OC2=CC3=C(C(=O)N=C(N3C=C2)C4=CC(=CC=C4)Cl)C5=CC(=CC=C5)Cl
|
| https://www.w3.org/2000/01/rdf-schema#label |
CP-91149
|
| gptkbp:IUPACName |
2-(3-chlorophenyl)-3-(4-chlorophenyl)-7-(2,6-dimethoxyphenoxy)-4-quinazolinone
|
| gptkbp:mechanismOfAction |
glycogen phosphorylase inhibitor
|
| gptkbp:molecularWeight |
515.38 g/mol
|
| gptkbp:PubChem_CID |
9832222
|
| gptkbp:bfsParent |
gptkb:glycogen_phosphorylase
|
| gptkbp:bfsLayer |
7
|